CLBK(CLBK)
CLBK
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $408M | $552M |
| Low | $407M | $541M |
| High | $408M | $563M |
| EBITDA Avg | $90M | $122M |
| Low | $90M | $120M |
| High | $90M | $124M |
| EBIT Avg | $77M | $104M |
| Low | $77M | $102M |
| High | $77M | $106M |
| Net Income Avg | $75M | $78M |
| Low | $74M | $77M |
| High | $76M | $79M |
| EPS Avg | $0.74 | $0.77 |
| Low | $0.73 | $0.76 |
| High | $0.75 | $0.78 |
| Analysts (Rev / EPS) | 1 / 1 | 2 / 2 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $71M | $133M | $135M | $133M | $137M | $140M | $142M |
| Low | $71M | $131M | $134M | $132M | $136M | $139M | $141M |
| High | $71M | $135M | $136M | $134M | $138M | $141M | $143M |
| EBITDA Avg | $16M | $29M | $30M | $29M | $30M | $31M | $31M |
| Low | $16M | $29M | $30M | $29M | $30M | $31M | $31M |
| High | $16M | $30M | $30M | $30M | $30M | $31M | $32M |
| EBIT Avg | $13M | $25M | $25M | $25M | $26M | $26M | $27M |
| Low | $13M | $25M | $25M | $25M | $26M | $26M | $27M |
| High | $13M | $25M | $26M | $25M | $26M | $27M | $27M |
| Net Income Avg | $15M | $20M | $20M | $19M | $19M | $19M | $20M |
| Low | $14M | $20M | $20M | $19M | $19M | $19M | $20M |
| High | $15M | $20M | $20M | $19M | $19M | $19M | $20M |
| EPS Avg | $0.15 | $0.20 | $0.20 | $0.19 | $0.19 | $0.19 | $0.20 |
| Low | $0.14 | $0.20 | $0.20 | $0.19 | $0.19 | $0.19 | $0.20 |
| High | $0.15 | $0.20 | $0.20 | $0.19 | $0.19 | $0.19 | $0.20 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |